543 Frizzled cysteine-rich domain-related
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 5 | 11.1 | 0.45× | q = 0.02 | |
| Nucleosides, nucleotides, and analogues | 0 | 6.3 | 0 | q = 3.3e-3 | |
| Lipids and lipid-like molecules | 11 | 2.5 | 4.36× | not tested | |
| Organic oxygen compounds | 17 | 4.5 | 3.77× | not tested | |
| Organic nitrogen compounds | 1 | 0.7 | 1.38× | not tested | |
| Homogeneous non-metal compounds | 6 | 4.9 | 1.23× | not tested | |
| Organoheterocyclic compounds | 2 | 3.5 | 0.57× | not tested | |
| Organic acids and derivatives | 2 | 3.5 | 0.57× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 69 |
| DB04257 | PAM | Palmitoleic Acid | 12 |
| DB00158 | FOL | Folic acid | 10 |
| DB04540 | CLR | Cholesterol | 6 |
| DB00642 | LYA | Pemetrexed | 3 |
| DB04038 | ERG | Ergosterol | 3 |
| DB05168 | — | — | 3 |
| DB00564 | N6W | Carbamazepine | 2 |
| DB02042 | 1PG | 2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol | 2 |
| DB00563 | MTX | Methotrexate | 1 |
| DB00606 | — | Cyclothiazide | 1 |
| DB00790 | — | — | 1 |
| DB00973 | — | Ezetimibe | 1 |
| DB01047 | — | — | 1 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 1 |
| DB04705 | HC3 | 25-Hydroxycholesterol | 1 |
| DB06786 | — | — | 1 |
| DB08878 | 04J | Aminopterin | 1 |
| DB09143 | — | — | 1 |
| DB11978 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 84 |
| CL | CHLORIDE ION | 25 |
| CLR | CHOLESTEROL | 16 |
| PAM | PALMITOLEIC ACID | 12 |
| ZNmetal | ZINC ION | 11 |
| Kmetal | POTASSIUM ION | 10 |
| CAmetal | CALCIUM ION | 9 |
| FOL | FOLIC ACID | 9 |
| 83A | N-(4-{[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)ethyl]amino}benzene-1-carbonyl)-L-glutamic acid | 8 |
| NAmetal | SODIUM ION | 8 |
| ERG | ERGOSTEROL | 7 |
| CCN | ACETONITRILE | 4 |
| CY8 | Cyclopamine | 3 |
| LYA | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | 3 |
| 1PG | 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL | 2 |
| N6W | benzo[b][1]benzazepine-11-carboxamide | 2 |
| NER | (15E)-TETRACOS-15-ENOIC ACID | 2 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 2 |
| 04J | Aminopterin | 1 |
| CXS | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID | 1 |